BURGUNDY DIAMOND MINES LIMITED (BDM)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
BDM - BURGUNDY DIAMOND MINES LIMITED
FNArena Sector :
NONE
Year End: December
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Debt/EBITDA: 1.02
Index:
FNArena Sector : NONE
Year End: December
GICS Industry Group : Pharmaceuticals, Biotechnology & Life Sciences
Debt/EBITDA: 1.02
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
|
$0.017
18 Dec |
0.000 OPEN $0.02 |
0.000 HIGH $0.02 |
0 LOW $0.02 |
| TARGET | |||||
|
|||||
FNARENA'S MARKET CONSENSUS FORECASTS
| Title | FY25 Forecast |
FY26 Forecast |
|---|---|---|
| EPS (cps) | N/A | xxx |
| DPS (cps) | N/A | xxx |
| EPS Growth | N/A | xxx |
| DPS Growth | N/A | xxx |
| PE Ratio | N/A | xxx |
| Dividend Yield | N/A | xxx |
| Div Pay Ratio(%) | N/A | xxx |
All estimates have been converted into AUD by FNArena at present FX values.
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
| Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| EPS Basic | xxx | xxx | xxx | xxx | xxx | -10.4 |
| DPS All | xxx | xxx | xxx | xxx | xxx | 0.0 |
| Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 670.3 M |
| Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 7.0 |
| Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 132.0 M |
| Net Profit Margin | xxx | xxx | xxx | xxx | xxx | -22.00 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
| Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | -88.80 % |
| Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | -49.48 % |
| Return on Assets | xxx | xxx | xxx | xxx | xxx | -17.11 % |
| Return on Equity | xxx | xxx | xxx | xxx | xxx | -88.80 % |
| Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 19.50 % |
| Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -17.3 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
| Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 15 M |
| Long Term Debt | xxx | xxx | xxx | xxx | xxx | 132 M |
| Total Debt | xxx | xxx | xxx | xxx | xxx | 147 M |
| Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | - |
| Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 41 M |
| Price To Book Value | xxx | xxx | xxx | xxx | xxx | 1.26 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross

Cash & Equivalents - Generic
Price To Book Value
| Title | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Capex | xxx | xxx | xxx | xxx | xxx | 149.3 M |
| Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 22.28 % |
| Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 562 M |
| Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 44 M |
| Research & Development | xxx | xxx | xxx | xxx | xxx | - |
| Investments - Total | xxx | xxx | xxx | xxx | xxx | 13 M |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development

Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
EXTRA COVERAGE
Display All Commentary
No. Of Recommendations
Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.
BDM STOCK CHART




